Medlab SB 5B (Saccharomyces cerevisiae)

Details

Saccharomyces cerevisiae ssp. boulardii (SB) is a beneficial probiotic yeast that helps to maintain gastrointestinal function and integrity by supporting a healthy gut microbial profile; by increasing the production of secretory IgA (sIgA), short-chain fatty acids (SCFAs) and helping to promote the activity of brush border disaccharide enzymes.

Saccharomyces cerevisiae ssp. boulardii (SB) has demonstrated efficacy in relieving diarrhoea severity and duration in both adults and children due to various triggers.

Saccharomyces cerevisiae ssp. boulardii (SB) assists in supporting healthy immune function and may help to reduce inflammatory mediators in the gastrointestinal tract.

Indications

STANDARD INDICATIONS

• Assist in the management of medically diagnosed irritable bowel syndrome.
• For the symptomatic relief of medically diagnosed irritable bowel syndrome.
• Helps maintain healthy digestive function.
• Aids assists or helps in the maintenance or improvement of general well-being.
• Relief or treatment of diarrhoea.
• Aids digestion.
• Treatment of mild digestive disorders.

SPECIFIC INDICATIONS

• Assists in the management of mild digestive disturbances including bloating, flatulence and digestive discomfort.
• May be used as a prophylactic for, or to support the relief of symptoms of infectious, antibiotic-associated and traveller's diarrhoea.
• Helps to support healthy immune function.
• Saccharomyces boulardii may competitively inhibit the binding of Candida albicans to the gastrointestinal mucosa.
• May help to reduce inflammatory mediators originating in the gastrointestinal tract.
• May assismulating secretion of disaccharidase brush border enzymes - sucrase, lactase and maltase assisting in the digestion and absorption of associated dietary compounds.
• Saccharomyces boulardii aids in the stimulation of secretory IgA release in the gastrointestinal tract that then targets potential pathogens.
• Saccahromyces boulardii produces protein-digesting enzymes (protease) that has shown in in vitro studies the ability to degrade/destroy Clostridium difficile toxin A and B.
• In vitro research demonstrates that Saccharomyces boulardii can block pathogen toxin receptor sites or can act as a decoy receptor for pathogenic toxins.
• Saccharomyces boulardii assists in the preservation of tight junctions between enterocytes and colonocytes that may help to reduce gut permeability and the translocation of bacteria from the gut lumen to the bloodstream.
• Research has demonstrated that when giving Saccharomyces boulardii at the same time as antibiotics that the normal microbiota is re-established more rapidly than when antibiotics are given without Saccharomyces boulardii.

• Saccharomyces boulardii increases the production of short chain fatty acids that function as signalling molecules to the body.

Dose

Take one (1) capsule, one (1) to two (2) times per day, or as directed by your healthcare practitioner.

Active Ingredients

*CFU: Colony Forming Units

Excipient Ingredients

Cellulose
Magnesium Stearate
Calcium Hydrogen Phosphate
Silica

Warnings

Always read the label.

Follow the directions for use. If symptoms persist, talk to your health professional. Seek medical advice if diarrhoea persists for more than: 6 hours in infants under 6 months; 12 hours in children under 3 years; 24 hours in children aged 3-6 years and 48 hours in children over 6 years and adults.

Side Effects

Saccharomyces cerevisiae ssp. boulardii (SB) has shown to be well tolerated in adults when taken orally for up to 15 month?s duration.

It can cause flatulence in some people. Infrequent cases of fungaemia have been reported in case reports but only in patients with serious diseases in which they have been hospitalised.

Saccharomyces cerevisiae ssp. boulardii (SB) has shown to be well tolerated in children when taken orally appropriately. However, a healthcare practitioner should evaluate diarrhoea in children before using Medlab SB 5B.

Interactions

Medications for fungal infections (i.e. dicflonac) interact with and reduce the therapeutic effectiveness of SB due to SB being a yeast.